Walsh Patrick D 4

What Happened

• Patrick D. Walsh, a director of ANI Pharmaceuticals (ANIP), sold a total of 13,973 shares in two open-market transactions. On 2026-05-11 he sold 3,973 shares at $80.75 each for $320,820, and on 2026-05-13 he sold 10,000 shares at $80.63 each for $806,300 — total proceeds ≈ $1,127,120. These were sales (transaction code S), which are often routine insider transactions and do not necessarily signal company fundamentals.

Key Details

• Transaction dates and prices:
  • 2026-05-11: 3,973 shares @ $80.75 → $320,820
  • 2026-05-13: 10,000 shares @ $80.63 → $806,300
• Total shares sold: 13,973; total proceeds ≈ $1,127,120.
• Transaction type: Open market sales (S).
• Filing: Form 4 filed 2026-05-13 (covers transactions dated 5/11 and 5/13); based on dates this filing appears timely.
• Shares owned after the transactions: Not specified in the provided filing details.
• Footnotes/plan details: None disclosed in the summarized data (no 10b5-1 plan, tax withholding, or other footnotes provided).

Context

• Sales by directors are common for liquidity, diversification, or personal reasons; they are different from purchases, which are often viewed as a stronger bullish signal. No option exercises, gifts, or awards were reported here — just open-market sales.